COVID Town Hall - Part 2 Save
Part II – Audience Questions
33:32 What about the timing of hydroxychloroquine use and for how long?
34:50 Should patients on bDMARDs or tsDMARDs (because of presumed risk) not go to work and should we write letters for such people?
37:05 Bush Administration disaster preparedness guidelines and supporting patients
39:06 What infusions should we not do? Denosumab? Zolendronic acid?
41:09 What to do about tocilizumab infusions being COVID diverted? What are the alternatives?
44:09 Should you start your lupus or RA patient on hydroxychloroquine or a new biologic in this era?
46:58 A patient has a resolved COVID-19 infection, would you start a biologic if needed?
47:21 Is anyone worried about the cardiotoxicity of hydroxychloroquine or chloroquine?
48:42 Would you the doctor, self-medicate, or prophylax, with HCQ if you have new onset suspicious symptoms?
50:04 Should rheumatologists do inpatient consults during the COVID?
51:30 If tests were universally available, would you test all your rheumatology patients for COVID-19?
Transcription
Doctor. Alan Matsumoto from the arthritis and rheumatism group in Maryland. Is that right, Alan? Yep, yes, Maryland and Washington. And then Cassie Calabrese from the Cleveland Clinic on my right.
On the bottom row, we have Alvin Wells from the Rheumatology and Immunotherapy Center in Wisconsin, Arti Kavanaugh from University of California, San Diego, Kevin Winthrop from Oregon Health and Science University Center in Portland, Oregon. Thank you for joining us, folks. Thank you, Jack. Right, so I wanna go with, and the general format here is we're gonna talk a few topics amongst the panelists in the first half of this hour, and then we're gonna get to all your questions. So if you're gonna ask questions, you can ask them using the Q and A button on Zoom.
On the bottom row, we have Alvin Wells from the Rheumatology and Immunotherapy Center in Wisconsin, Arti Kavanaugh from University of California, San Diego, Kevin Winthrop from Oregon Health and Science University Center in Portland, Oregon. Thank you for joining us, folks. Thank you, Jack. Right, so I wanna go with, and the general format here is we're gonna talk a few topics amongst the panelists in the first half of this hour, and then we're gonna get to all your questions. So if you're gonna ask questions, you can ask them using the Q and A button on Zoom.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.